Antiphospholipid Syndrome Collaborative Registry (APSCORE) (APSCORE)
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
This observational or N/A phase trial investigates Antiphospholipid Syndrome and is currently completed. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) leads this study, which shows 10 recorded versions since 2000 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 5 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Apr 2000
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- National Institute on Minority Health and Health Disparities (NIMHD)
- University of North Carolina, Chapel Hill
For direct contact, visit the study record on ClinicalTrials.gov .